Home›People›Marc Becker
MB

Marc Becker

Chief Financial Officer and Chief Operating Officer at Ratio Therapeutics.

Executive
Updated Nov 9, 2026·Latest SEC filing Jul 31, 2026·Suggest an edit

About Marc Becker

Marc Becker is a chief financial officer and chief operating officer at Ratio Therapeutics.

Experience

This experience comes from Marc Becker's profile and from SEC filings. For roles taken from filings, the years are when the filings name Marc Becker in the role, so the role may have started earlier or lasted longer.

Ratio Therapeutics, Inc. Current
CFO & COO
2024 – Present · Boston, MA
Develops targeted radioactive medicines for people with cancer.
Flagship Pioneering
CFO - Growth Companies
2023 – 2024
Food For Free
Director
2018 – 2023
Concert Pharmaceuticals, Inc.
CFO
2018 – 2023
CRISPR Therapeutics
CFO
2016 – 2017
rEVO Biologics
CFO
2012 – 2016
Genzyme
Global VP Finance
2001 – 2011
BankBoston
Commercial Credit / Telecom & Technology
1999 – 2000
KPMG
Audit Senior
1994 – 1998

Key Colleagues at Startups

The people Marc Becker works with at each company, as listed on that company's latest Form D.

Ratio Therapeutics, Inc. · Form D, Jul 31, 2026
SM
Scott MacDonald
Executive officer
AH
AG
Allan Green
Director
WC
JH
John Hoppin
Chief Executive Officer and director
JB
John Babich
Chief Scientific Officer and director
SW

Sources

  1. SECRatio Therapeutics, Inc. Form D, filed Jul 31, 2026